Natera, Inc. (NTRA)
404.91
+0.96
(+0.24%)
USD |
NASDAQ |
Oct 26, 16:00
404.91
0.00 (0.00%)
After-Hours: 18:06
Natera Net Income (TTM) : -192.35M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -192.35M |
| March 31, 2026 | -226.32M |
| December 31, 2025 | -208.16M |
| September 30, 2025 | -309.19M |
| June 30, 2025 | -253.24M |
| March 31, 2025 | -189.76M |
| December 31, 2024 | -190.43M |
| September 30, 2024 | -214.69M |
| June 30, 2024 | -292.12M |
| March 31, 2024 | -365.46M |
| December 31, 2023 | -434.80M |
| September 30, 2023 | -499.34M |
| June 30, 2023 | -511.79M |
| March 31, 2023 | -546.14M |
| December 31, 2022 | -547.80M |
| September 30, 2022 | -545.79M |
| June 30, 2022 | -575.58M |
| March 31, 2022 | -546.46M |
| December 31, 2021 | -471.72M |
| September 30, 2021 | -407.56M |
| June 30, 2021 | -314.61M |
| March 31, 2021 | -258.22M |
| December 31, 2020 | -229.74M |
| Date | Value |
|---|---|
| September 30, 2020 | -188.52M |
| June 30, 2020 | -153.33M |
| March 31, 2020 | -126.11M |
| December 31, 2019 | -124.83M |
| September 30, 2019 | -121.48M |
| June 30, 2019 | -127.96M |
| March 31, 2019 | -129.37M |
| December 31, 2018 | -128.15M |
| September 30, 2018 | -143.53M |
| June 30, 2018 | -141.78M |
| March 31, 2018 | -137.02M |
| December 31, 2017 | -137.63M |
| September 30, 2017 | -128.32M |
| June 30, 2017 | -126.47M |
| March 31, 2017 | -120.56M |
| December 31, 2016 | -95.76M |
| September 30, 2016 | -80.82M |
| June 30, 2016 | -72.43M |
| March 31, 2016 | -68.96M |
| December 31, 2015 | -70.28M |
| September 30, 2015 | -43.59M |
| June 30, 2015 | -26.48M |
| March 31, 2015 | -16.41M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Guardant Health, Inc. | -453.44M |
| Myriad Genetics, Inc. | -112.60M |
| CareDx, Inc. | 111.01M |
| Caris Life Sciences, Inc. | 105.14M |
| BioRestorative Therapies, Inc. | -11.06M |